BY MARKETWIRE
-
Demant gained and GN lost market share with US veterans
Demant’s market share expanded to 18.7% from 18.6% in February, while GN’s share was up to 9.4% from 9.5%.
-
Swedish medtech group dives after mixed results and greater uncertainty
On the leading line, nonetheless, the medtech business has actually gotten to the goal in the initial quarter with earnings development.
-
Danaher surprises positively with Q1 sales and operating income
Both sales and running revenue surpassed experts’ assumptions in the initial quarter for the United States clinical gadget team Danaher.
-
Analyst lowers expectations for Novo Nordisk after Lilly’s new weight-loss study
Intron Health and wellness is decreasing its price quotes for Novo Nordisk by 2030. Sales price quotes have actually been reduced by 20%, while profits per share assumptions have a…
-
Novo Nordisk faces pressure after new data from Eli Lilly
The most recent information from Eli Lilly’s weight-loss tablet computer will certainly position extra needs on technology at Novo Nordisk, states expert.
-
Johnson & Johnson’s Darzalex sales beat analysts’ outlook
Sales completing greater than USD 3bn have actually gone beyond experts’ assumptions.
-
Pfizer discontinues development of weight-loss tablet after subject suffers liver damage
The choice is based upon liver damages in among the clients in the continuous Stage 3 research and is likewise based upon input from the authorities.
-
Johnson & Johnson’s Darzalex sales beat analysts’ outlook
Sales totaling more than USD 3bn have exceeded analysts’ expectations.
-
Novartis to invest billions in US-based drug facilities
A USD 23bn amount is prepared to money a proving ground in The golden state, 4 production centers, and development of existing manufacturing facilities throughout the United States…
-
Bavarian Nordic shareholders with clear call to management: Market confidence must be restored
This objection was articulated by numerous investors at the AGM on Wednesday, where both Danish pension plan fund ATP and the mutual fund Basic Invest blasted the vaccination busin…